DMIIR
NASDAQ
US
Drugs Made In America Acquisition II Corp. - Right
N/A
· N/A
· IPO Sep 2025
$0.08
▲ +$0.00
(+0.00%)
Vol 4K
Beta
-0.11
52W
$10–$10
Price Chart
Key Ratios
52W High
$9.92
52W Low
$9.86
$9.86
52-Week Range
$9.92
How does DMIIR compare to N/A peers?
Peer group: Micro-cap N/A (All) · 453 companies
DMIIR valuation vs N/A peers
P/E ratio
—
▼
0%
below
peers
(56.5)
vs Peers
vs Industry
Fair value
P/S ratio
—
▼
0%
below
peers
(6.0)
vs Peers
vs Industry
Undervalued
P/B ratio
—
▼
0%
below
peers
(1.3)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(19.6%)
vs Peers
vs Industry
Low yield
DMIIR profitability vs N/A peers
ROE
—
▼
0%
below
peers
(2.8%)
vs Peers
vs Industry
In line
Net margin
—
▼
0%
below
peers
(0.8%)
vs Peers
vs Industry
Weak
Gross margin
—
▼
0%
below
peers
(63.5%)
vs Peers
vs Industry
Weak
ROA
—
▼
0%
below
peers
(2.6%)
vs Peers
vs Industry
In line
DMIIR financial health vs N/A peers
D/E ratio
—
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
High debt
Current ratio
—
▼
0%
below
peers
(1.1)
vs Peers
vs Industry
Strong liquidity
Beta
-0.1
▼
636%
below
peers
(0.0)
vs Peers
vs Industry
More volatile
DMIIR fundamentals radar
DMIIR
Peer median
Industry
DMIIR profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
DMIIR vs peers: key metrics
Latest News
No related news yet